Routine use of loop diuretics during morcellation does not improve holmium laser enucleation of the prostate outcomes

A prospective, double-blind, randomized controlled trial

Auteurs-es

  • Nick S. Dean University of Alberta
  • Perry J. Xu Northwestern University
  • Kyle Tsai Northwestern University
  • Alyssa McDonald Northwestern University
  • Allaa Fadl-Alla Northwestern University
  • Jenny N. Guo Northwestern University
  • Amy E. Krambeck Northwestern University

DOI :

https://doi.org/10.5489/cuaj.9842

Mots-clés :

HOLEP, Lasix, BPH

Résumé

Introduction: Loop diuretics have been administered historically during morcellation to promote urine production postoperatively and to minimize the impact of fluid absorption during holmium laser enucleation of the prostate (HoLEP) procedures. Despite the widespread use of furosemide, no prior study has examined the effects of this medication on postoperative outcomes, including same-day discharge (SDD), same-day trial of void (SDTOV), re-admission rates, or fluid overload. We sought to compare outcomes of HoLEP with and without the use of an intraoperative furosemide.

Methods: From January 2023 to June 2023, we prospectively randomized 138 patients undergoing HoLEP 1:1 to receive or not receive 20 mg of IV furosemide during morcellation (STU00217795). Our primary outcome was to compare rates of SDD between those who receive furosemide at time of HoLEP vs. controls. Secondary outcomes included intraoperative efficiencies and postoperative clinical outcomes.

Results: There was no difference in demographics and prostate features between patients randomized to furosemide (n=69) vs. controls (n=69). Patients receiving furosemide were less likely to undergo a SDTOV attempt (furosemide: 81.6% vs. control: 97.0%, p=0.005) and to achieve SDD (furosemide: 63.6% vs. control: 81.8%, p=0.019). There was no difference between the cohorts in the rates of failed SDTOV, mean length of stay (LOS), or mean catheterization time. No patients in either group experienced symptomatic postoperative fluid overload.

Conclusions: IV furosemide administered during HoLEP does not improve rates of SDD, SDTOV, LOS, duration of catheterization, or adverse event rates. Routine intraoperative furosemide administration does not appear to have a role within a contemporary HoLEP treatment pathway.

Téléchargements

Les données relatives au téléchargement ne sont pas encore disponibles.

Publié-e

2026-11-20

Comment citer

Dean, N. S., Xu, P. J., Tsai, K., McDonald, A., Fadl-Alla, A., Guo, J. N., & Krambeck, A. E. (2026). Routine use of loop diuretics during morcellation does not improve holmium laser enucleation of the prostate outcomes: A prospective, double-blind, randomized controlled trial. Canadian Urological Association Journal, 21(3). https://doi.org/10.5489/cuaj.9842

Numéro

Rubrique

Original Research